UPDATED May 11, 2024
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CABP | UK£1.38 | -1.4% | n/a | UK£350.7m | UK£1.78 | PE15.3x | E34.6% | n/a | Diversified Financials | ||
SPSY | UK£2.31 | 4.5% | 33.9% | UK£110.5m | UK£3.52 | PE22.9x | E26.3% | 4.0% | Tech | ||
MGAM | UK£3.27 | 3.8% | 13.8% | UK£929.1m | UK£3.68 | PE19.9x | E23.4% | 3.7% | Capital Goods | ||
IDHC | US$0.33 | 3.5% | -29.9% | US$196.8m | n/a | PE18.3x | E27.9% | n/a | Healthcare | ||
FSG | UK£4.57 | -0.2% | 11.2% | UK£529.7m | UK£5.95 | PE25.3x | E28.9% | 4.9% | Diversified Financials | ||
PAF | UK£0.25 | 5.2% | 40.0% | UK£483.9m | n/a | PE8.1x | E30.2% | 3.0% | Materials | ||
TPFG | UK£4.00 | 2.6% | 27.0% | UK£249.3m | UK£4.96 | PE33.7x | E36.7% | 3.0% | Real Estate Management and Development | ||
AZN | UK£123.70 | 2.7% | 3.0% | UK£191.8b | UK£133.20 | PE37.9x | E15.9% | 2.0% | Pharmaceuticals & Biotech | ||
EMG | UK£2.58 | -2.9% | 21.6% | UK£3.0b | UK£3.05 | PE16.1x | E19.5% | 5.1% | Diversified Financials | ||
MTO | UK£1.20 | 3.6% | 29.8% | UK£1.5b | UK£1.41 | PE15.2x | E13.0% | 2.7% | Commercial Services | ||
GMR | UK£0.41 | 12.3% | 26.4% | UK£119.8m | n/a | PE20.2x | E21.9% | n/a | Media | ||
TBCG | UK£30.00 | 0.2% | 28.5% | UK£1.6b | UK£39.68 | PB1.2x | E15.2% | 7.2% | Banks |